Democratic presidential candidates Hillary Clinton and Bernie Sanders both criticized the planned merger of Pfizer and Allergan, which would produce the world’s largest pharmaceutical company and allow Pfizer to reduce its taxes by moving its legal residence overseas.
The $160 billion deal, announced Monday, would be the largest-ever corporate inversion, a type of transaction in which an American company merges with a foreign company and then reincorporates the combined company overseas to reduce its tax burden.
Clinton said that in the coming weeks she will “propose specific steps to prevent these kind of transactions, which take advantage of loopholes that litter our tax code, distort incentives for investment, and disadvantage small businesses and domestic firms that cannot game the international tax system.”
After the Pfizer-Allergan merger is closed, the combined company is expected to keep Allergan’s Irish legal residence. The merged company is expected to have an adjusted effective tax rate of 17 to 18 percent in the first full year after the transaction is closed, compared with Pfizer’s expected 25 percent effective tax rate for 2015, according to a Pfizer spokesman.
Clinton called upon regulators to see if they can take stronger actions to prevent corporations from moving earnings overseas, and she urged Congress to “act immediately to make sure the biggest corporations pay their fair share.”
“Republicans should stop trying to tilt the tax code even further in favor of the super wealthy and the largest corporations and join us in supporting these necessary reforms on behalf of U.S. taxpayers,” the former Secretary of State said.
Sanders criticized the merger not just because it would allow Pfizer to “hide its profits overseas” but also because it would hurt those who need prescription medications.
Full content: Time
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Redfin Settles $9.2M Commission Inflation Lawsuits
May 7, 2024 by
CPI
DOJ Supports Colorado’s Efforts to Block Kroger-Albertsons Merger
May 7, 2024 by
CPI
Japan Considers Regulation of AI Developers
May 7, 2024 by
CPI
European Commission Extends Decision Deadline for Ita-Lufthansa Merger
May 7, 2024 by
CPI
UK, US and Australia Sanction Senior Leader of LockBit Cybercrime Gang
May 7, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI